SYRS — Syros Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$17.19m
- $9.94m
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial
Syros Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Syros Reports Third Quarter 2024 Financial Results
Brief: Syros Pharmaceuticals Q3 EPS USD -0.16 Vs. IBES Estimate USD -0.72
Syros Pharmaceuticals Inc expected to post a loss of 72 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Paysafe, HUYA, Oklo
U.S. STOCKS ON THE MOVE-Penumbra, Talen Energy, Paysafe
U.S. STOCKS ON THE MOVE-Apollomics, Syros Pharmaceuticals, Buzzfeed
Syros Pharma slumps as blood cancer therapy combo 'unlikely to succeed' in study
Brief: Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
Brief: Syros Pharmaceuticals Q2 EPS USD -0.59 Vs. IBES Estimate USD -0.77
Syros Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Syros Pharmaceuticals Q1 EPS USD -0.1 Vs. IBES Estimate USD -0.87
Syros Pharmaceuticals Inc expected to post a loss of 87 cents a share - Earnings Preview
Syros Pharmaceuticals Inc expected to post a loss of 87 cents a share - Earnings Preview
Brief: Syros Receives Fast Track Designation From FDA For Tamibarotene